Dyslipidemia is a protective factor in amyotrophic lateral sclerosis

2008538 citationsJournal Article

Authors

Luc Dupuis · Inserm

P. Corcia · Inserm

Anissa Fergani · Inserm

José‐Luis González de Aguilar · Inserm

Dominique Bonnefont‐Rousselot · Inserm

Randa Bittar · Inserm

Danielle Seilhean · Inserm

Abstract

Hyperlipidemia is a significant prognostic factor for survival of patients with amyotrophic lateral sclerosis. This finding highlights the importance of nutritional intervention strategies on disease progression and claims our attention when treating these patients with lipid-lowering drugs.

Topics & Keywords

Amyotrophic Lateral Sclerosis Research Parkinson's Disease Mechanisms and Treatments Alzheimer's disease research and treatments

UN Sustainable Development Goals

Zero hunger

Publication Details

Published in: Neurology

Volume 70, Issue 13, pp. 1004-1009

DOI: 10.1212/01.wnl.0000285080.70324.27

Field-Weighted Citation Impact: 19.79